Outcome of patient with high-risk chronic myelomonocytic leukemia, treated with decitabine prior to transformation to acute myeloid leukemia: A case report

The present study describes a patient with high-risk chronic myelomonocytic leukemia (CMML), for whom decitabine therapy achieved partial remission, prior to a sudden transformation to acute myeloid leukemia (AML) and an inferior outcome. The 53-year-old male reported easily bruising for 5 months. E...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Huan, Cheng, Juan, Zhao, Long, Xu, Qian, Xue, Mingming, Zhang, Shuling, Liu, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921036/
https://www.ncbi.nlm.nih.gov/pubmed/29731877
http://dx.doi.org/10.3892/ol.2018.8236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921036/
https://www.ncbi.nlm.nih.gov/pubmed/29731877
http://dx.doi.org/10.3892/ol.2018.8236

Ejemplares similares